- Around 1,800 people were diagnosed with Hodgkin lymphoma in 2011 in the UK, that’s around 5 people every day.
- Hodgkin lymphoma can develop at any age, but there are two peaks in incidence – in young adults, and older men and women.
- 1 in 10 Hodgkin lymphomas are diagnosed in people aged 75 and over.
- Around 1 in 5 Hodgkin lymphoma cases occur in children, teenagers and young adults (up to age 24).
- Overall, Hodgkin lymphoma incidence rates have remained stable for males and increased for females since the mid-1970s, though for both sexes there was a decrease from the mid-1970s until the 1990s, followed by an increase to the present.
- Most Hodgkin lymphoma cases are diagnosed at an early stage.
- Worldwide there were estimated to be around 68,000 new cases of Hodgkin lymphoma in 2008, and more than half of these were in developing countries.
Hodgkin lymphoma statistics
New cases of Hodgkin lymphoma, 2011, UK
Deaths from Hodgkin lymphoma, 2012, UK
Survive Hodgkin lymphoma for 10 or more years, 2010-11, England and Wales
Preventable cases of Hodgkin lymphoma, UK
- More than a third of Hodgkin lymphoma deaths occur in people aged 75 and over.
- In the UK there were more than 330 deaths from Hodgkin lymphoma in 2012, that is more than 6 people every week.
- Hodgkin lymphoma death rates in the UK have fallen by 75% over the last forty years.
- Worldwide, around 25,500 people were estimated to have died from Hodgkin lymphoma in 2012, with mortality rates varying across the world.
- In Europe, around 4,600 people were estimated to have died from Hodgkin lymphoma in 2012. The UK mortality rate is 19th lowest in Europe for males and 13th highest for females.
- Overall, 8 in 10 people diagnosed with Hodgkin lymphoma now survive their disease for at least ten years.
- Ten-year survival for Hodgkin lymphoma has increased by 33 percentage points in the last forty years.
- Ten-year survival for Hodgkin lymphoma ranks 4th highest out of 20 common cancers in England and Wales.
- 45% of Hodgkin lymphoma cases each year in the UK are linked to major lifestyle and other risk factors.
- A person’s risk of developing Hodgkin lymphoma depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- Evidence on Hodgkin lymphoma risk factors is limited, mainly because this cancer is relatively rare and comprises many subtypes.
- Epstein-Barr virus is the main potentially avoidable risk factor for Hodgkin lymphoma, linked to an estimated 45% of Hodgkin lymphoma cases in the UK.
- Human immunodeficiency virus (HIV) causes Hodgkin lymphoma.
- Problems with the immune system, overweight and obesity, and smoking may relate to higher Hodgkin lymphoma risk.
- GP referral (not ‘two-week wait’) is the most common route to diagnosis of Hodgkin lymphoma.
- ‘Two-week wait’ and ’31-day wait’ standards are met by all countries, and ‘62-day wait’ is not met by any country for haematological cancers.
The latest statistics available for Hodgkin lymphoma in the UK are; incidence 2011, mortality 2012 and survival 2010-2011.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Overall, the evidence on Hodgkin lymphoma risk factors is limited, mainly because of this cancer's relative rarity and diversity. Studies which group together different morphological subtypes of Hodgkin lymphoma may be confounded if those subtypes have differing aetiologies.
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2006-2010.
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Hodgkin lymphoma is part of the group 'Haematological cancers' for cancer waiting times data. Codes vary per country but broadly include: Hodgkin lymphoma, follicular and non-follicular lymphoma, mature T/NK-cell lymphoma, other and unspecified types of NHL, other and unspecified types of T/NK-cell lymphoma, malignant immunoproliferative diseases, myeloma, lymphoid, myeloid and monocytic leukaemia, some other leukaemia of specific or unspecified cell type, and other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue.
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.